openPR Logo
Press release

HEC, Henan Huaxing, Kelun, Lijun and Ningxia Qiyuan are the major players of the Erythromycin Thiocyanate Market

10-12-2018 08:18 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Cosmos

HEC, Henan Huaxing, Kelun, Lijun and Ningxia Qiyuan are the major

Global Erythromycin Thiocyanate Market Overview:
Erythromycin Thiocyanate is a commonly used macrolide antibiotic. It is a veterinary product for the treatment of infections by gram-positive bacteria and mycoplasma. It has been widely used as an animal growth promoter. In China, with tylosin, tetracycline and oxytetracycline, these are the most important veterinary antibiotic products exported. In addition, the product is used as an important intermediate in the synthesis of conventional macrolide antibiotics, for example, erythromycin, roxithromycin, azithromycin and clarithromycin. China started production of erythromycin thiocyanate in the 1980s to 1990s, but the yield was less than 100 tons. In 2007, it became the largest macrolide antibiotic exporter, with a production capacity of more than 10,000 tons. The antibacterial spectrum of erythromycin thiocyanate is similar to that of benzylpenicillin.

Browse report brief and TOC @ https://www.researchcosmos.com/reports/erythromycin-thiocyanate-market-research-report-global-industry-analysis-and-forecast-2017-to-2022/224142596

It has a potent effect against Staphylococcus aureus bacteria, streptococci and pneumonia in Gram-positive bacteria, as well as some effects on Pasteurella and Brucella in Gram-negative bacteria. In addition, the product is effective against mycoplasmas, rickettsiae, leptospires, actinomycetes and ardias, but not against echerichia coli, salmonella and other negative intestinal bacteria. It is mainly used for serious infections caused by drug-resistant Staphylococcus aureus and hemolytic streptococci, such as pneumonia, sepsis, endometritis and mastitis. In addition, it also has a beneficial effect on chronic respiratory diseases caused by mycoplasma in porcine mycoplasma pneumonia and in poultry. On the other hand, it is also used for the treatment of nocardiosis in dogs and cats, for the prevention of the disease of the white head and mouth of black carp, grass, and greyhound and other fish species, bacterial gill disease and carp blackfish disease, white silver, bighead carp and other fish, and tilapia streptococcal disease.

Global Erythromycin Thiocyanate Market Drivers and Restraints:
The usage of Erythromycin Thiocyanate is growing day by day due to its antibiotic qualities, which is majorly driving the growth of the market. Increasing cases of respiratory diseases are also supporting the growth of the market. Erythromycin Thiocyanate is also used as antibiotics for animals such as dogs and cats. It is observed that the adoption of dogs and cats has been growing eventually in recent times thus driving the growth of the market. Growing production facilities, as well as demand from several segments, are driving the boom of the market.

Request free sample @ https://www.researchcosmos.com/request/erythromycin-thiocyanate-market-research-report-global-ind/224142596

Geographic Insights:
Global Erythromycin Thiocyanate Market is segmented into regions such as North America, Europe, Latin America, Middle East and Africa, and Asia Pacific regions.  North America and Europe regions are estimated to be the largest contributors to the market. However, Asia Pacific region is estimated to grow faster with decent CAGR in forecasted years. The Middle East and Africa region is predicted to be growing at a slower pace in the coming years.

HEC, Henan Huaxing, Kelun, Lijun and Ningxia Qiyuan are the major players of the market.

About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.  

Contact: 
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
www.researchcosmos.com
+1 888 709 8757   
LinkedIn - https://www.linkedin.com/company/market-research-cosmos
Twitter - https://twitter.com/researchcosmos
Google+ -  https://plus.google.com/109756852849129986268
Facebook - https://www.facebook.com/researchcosmos/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HEC, Henan Huaxing, Kelun, Lijun and Ningxia Qiyuan are the major players of the Erythromycin Thiocyanate Market here

News-ID: 1298603 • Views:

More Releases from Research Cosmos

Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking. Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834 Growing utilization
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By 2025 | Leading Market Players - Kudos, Achievers Corp., REFFIND Ltd., Globoforce, Terryberry, Ultimate Software, Peoplecart, CorporateRewards
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview: Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period. Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of

More Releases for Erythromycin

Erythromycin Market Sees Steady Demand in Dermatology and Respiratory Treatments …
Erythromycin Market Overview Global erythromycin market is projected to grow from USD 17.7 billion in 2023 to USD 29.2 billion by 2032, registering a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period. The latest report (2025-2032) on the Erythromycin Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods
Erythromycin Market is Booming Worldwide with Players : Pfizer Inc , Abbott Labo …
The latest study released on the Global Erythromycin Market by HTF MI evaluates market size, trend, and forecast to 2030. The Erythromycin market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in This Report
Erythromycin Prices, Chart, Trend, Index 2024 & Forecast Analysis
𝐄𝐫𝐲𝐭𝐡𝐫𝐨𝐦𝐲𝐜𝐢𝐧 𝐏𝐫𝐢𝐜𝐞 𝐈𝐧 𝐔𝐒𝐀 • 𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬: 159264 USD/MT The Q2 price of erythromycin in the United States reached 159,264 USD/MT in June 2023. The latest report by IMARC Group, titled "𝐄𝐫𝐲𝐭𝐡𝐫𝐨𝐦𝐲𝐜𝐢𝐧 𝐏𝐫𝐢𝐜𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟒: 𝐏𝐫𝐢𝐜𝐞 𝐓𝐫𝐞𝐧𝐝, 𝐂𝐡𝐚𝐫𝐭, 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐍𝐞𝐰𝐬, 𝐃𝐞𝐦𝐚𝐧𝐝, 𝐇𝐢𝐬𝐭𝐨𝐫𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐃𝐚𝐭𝐚," provides a thorough examination of the 𝐄𝐫𝐲𝐭𝐡𝐫𝐨𝐦𝐲𝐜𝐢𝐧 𝐏𝐫𝐢𝐜𝐞𝐬. This report delves into the price of Erythromycin globally, presenting a detailed analysis, along with informative Price Chart. Through
Erythromycin Market 2022 [Future SCOPE] is Going to Boom with Abbott, Abbvie, Pf …
Coherent Market insight has added a new research study titled "Erythromycin Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities)", size, share, and outlook. The "Erythromycin Market" Research Report is an in-depth study with top-notch information on company size, current trends, drivers, outcomes, and significant market segments. The report offers useful insights into potential market growth based on input from industry experts to help readers
Erythromycin Market: Health and Economic Effects in the Pharmaceutical Industry: …
Industrial Growth Forecast Report Erythromycin Market 2021-2027: The Global Erythromycin Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Erythromycin Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application. New traders at intervals the Erythromycin Market face
Global Erythromycin Estolate Market Analysis by 2020-2025
Scope of the Report: The global Erythromycin Estolate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Market segmentation Erythromycin Estolate market is split by Type and by Application. For the period 2015-2025, the growth among segments